MedPath

Cayenne Pepper Cataplasm - Effect Study

Not Applicable
Completed
Conditions
Back Pain
Low Back Pain
Interventions
Other: Placebo Cataplasm
Other: Cayenne Pepper Cataplasm
Registration Number
NCT02705209
Lead Sponsor
Ludwig Boltzmann Institute of Electrical Stimulation and Physical Rehabilitation
Brief Summary

The beneficial analgesic effects of Rubefacenciae (redden skin substances), is known since 1830 as a treatment for pain, cramps, and disorders of the musculoskeletal system. Herbal cataplasms containing rubefacient substances, such as Cayenne pepper, are commonly used as natural medications to treat painful or aching areas in the case of acute or chronic back pain, and rheumatisms. In Vienna and lower Austria, a Cayenne Pepper Cataplasm (CPC) application containing Cayenne pepper and Kaolin powder in mixed proportion, is commonly used to treat musculoskeletal conditions of pain especially of the low back.

Therefore, the aim of the present study was to test effects of a series of ten applications of CPC prepared with 5% of pepper, investigating the resulting effect on: skin temperature, skin sensory functions, pain threshold, and proprioception. Placebo control condition (0% cayenne pepper) was also tested. It was hypothesized that a series of 20-minute application of a CPC will have significant effects on the measured parameters.

40 subjects will be randomized into Treatment/control group.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • chronic lumbar spine pain >= 3 months
  • pain during activity VAS >= 4
  • Oswestry Disabilty Index >= 20%
Exclusion Criteria
  • pregnancy
  • sensibility disorders (e.g. due to neurological disease)
  • injuries, open wounds or rash in intervention area
  • known hypersensitivity against the applied substances
  • HIV, Hepatitis C and other due blood communicable infectious diseases

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlPlacebo Cataplasm-
TreatmentCayenne Pepper Cataplasm-
Primary Outcome Measures
NameTimeMethod
Two-point discrimination testbefore 1st and 3 weeks later after 10th intervention

The subject is lying prone during the test and test will be performed with a BASELINE Aesthesiometer (0-100mm). The test will be performed at the level of L3 spinal process, the medial pin 3 cm laterally from midline and the pins oriented in medial-lateral direction. The two pins will be pressed perpendicular to the skin and the subject will be asked to report whether he/she feels one or two pins. Each inter-pin distance will be used three times using single pin touches in between for a control. The smallest inter-pin distance which the subject reports correctly at least 2 out of 3 repetitions, will be taken, as the result of the test.

Secondary Outcome Measures
NameTimeMethod
Monofilament Testbefore 1st and 3 weeks later after 10th intervention

Different monofilaments (Semmes-Weinstein) will be randomly pressed perpendicular to the same area as primary outcome measure. The thinest filament recognized from the subject will be taken as the result of the test.

Blood Samplebefore, 1h and 48h after the first intervention and 3 weeks later before, 1h and 48h after 10 interventions

test: hemogram, CRP, CK, blood sedimentation rate, albumin and different molecular markers

Skin Temperaturebefore 1st and 3 weeks later after 10th intervention

measured via Infrared thermometer

Range of Motion (thoracic and lumbar spine)before 1st and 3 weeks later after 10th intervention

Measured according to Schober and Ott test

Trial Locations

Locations (2)

Facultiy of Physical Education and Sports, Comenius University of Bratislava

🇸🇰

Bratislava, Slovakia

Ludwig Boltzmann Institute of Electrical Stimulation and Physical Rehabilitation

🇦🇹

Vienna, Austria

© Copyright 2025. All Rights Reserved by MedPath